Development of indicators and analysis of barriers for assessment and prevention of cutaneous graft-versus-host disease after haematopoietic stem cell transplantation in children

Development of indicators and analysis of barriers for assessment and prevention of cutaneous graft-versus-host disease after haematopoietic stem cell transplantation in children

Objective·To gain a comprehensive understanding of the current clinical status of assessment and prevention of cutaneous graft-versus-host disease (GVHD) after haematopoietic stem cell transplantation in children, construct review indicators, analyze obstacles and facilitators in the process of cond...

Full description

Saved in:

Bibliographic Details
Main Authors:	YANG Liling, ZHAN Sha, XUE Xiaoyan, CHEN Kai, LIU Qing, WANG Li, WANG Yiyi, WU Meng, LU Qunfeng
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science) 2024-12-01
Series:	Shanghai Jiaotong Daxue xuebao. Yixue ban
Subjects:	haematopoietic stem cell transplantation graft-versus-host disease (gvhd) review of indicator development barrier factor evidence-based nursing
Online Access:	https://xuebao.shsmu.edu.cn/article/2024/1674-8115/1674-8115-2024-44-12-1552.shtml
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review
by: Abhinav Bhattarai, et al.
Published: (2024-12-01)

Four cases of renal injury associated with allogeneic haematopoietic stem cell transplantation and literature review
by: Dong Ze-xuan, et al.
Published: (2025-01-01)

Elephantiasis nostra verrucosa in sclerodermatous chronic graft-versus-host disease
by: Jamila Mammadova, MD, MA, et al.
Published: (2025-03-01)

Lung transplantation for pulmonary chronic graft-versus-host disease: a missed opportunity?
by: Andrea Zajacova, MD, et al.
Published: (2025-02-01)

Efficacy and safety of human umbilical cord-derived mesenchymal stem cells versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease: a multicentre, randomized, double-blind, phase 2 trial
by: Erlie Jiang, et al.
Published: (2024-11-01)

Etanercept on steroid-refractary acute graft-versus-host disease
by: Silvia González Munguía, et al.
Published: (2015-02-01)

Vaccination After Haematopoietic Stem Cell Transplant: A Review of the Literature and Proposed Vaccination Protocol
by: André Silva-Pinto, et al.
Published: (2024-12-01)

Acute graft-versus-host disease: a case report
by: JIANG Yuyang, et al.
Published: (2025-01-01)

Inflammasomes: potential therapeutic targets in hematopoietic stem cell transplantation
by: Jieya Luo, et al.
Published: (2024-12-01)

THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
by: Lucrezia Laterza, et al.
Published: (2016-05-01)

Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
by: Erika S Varady, et al.
Published: (2023-08-01)

Comparative retrospective analysis of cord blood transplantation with ATG-containing conditioning regimens and haploidentical stem cell transplantation: similar survival outcomes with reduced incidence of GVHD
by: Yongjia Liu, et al.
Published: (2025-12-01)

Graft-versus-host disease variety toxic epidermal necrolysis. Case report
by: Elsa M. Zúñiga-Lara, et al.
Published: (2024-01-01)

Targeting the chemokines in acute graft-versus-host disease
by: Ziwei Xu, et al.
Published: (2025-01-01)

Intra-mesenteric steroids for steroid-refractory graft-versus-host disease in pediatric patients: A safe option
by: Ana M. Aristizábal, et al.
Published: (2024-12-01)

Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions
by: Muhammad Azhar Ud Din, et al.
Published: (2025-01-01)

The history of haploidentical stem cell transplantation: a trip from the bench to the bedside
by: Mariana G. Meade, et al.
Published: (2024-12-01)

Case report: Toxic epidermal necrolysis as a unique presentation of acute graft versus host disease in a pediatric patient
by: Elizabeth Marlowe, et al.
Published: (2025-01-01)

Purpura Fulminans from Capnocytophaga canimorsus in an Immunocompromised Host
by: Indumathy Varadarajan, et al.
Published: (2024-10-01)

Time in therapeutic range of tacrolimus in allogeneic hematopoietic stem cell transplant recipients is associated with acute graft-versus-host disease prophylaxis
by: Naoki Yoshikawa, et al.
Published: (2025-01-01)

Ocular graft host disease after allogeneic stem cell transplant: unique risk factors and outcomes
by: Maaly A.M Abdel Fattah, et al.
Published: (2024-04-01)

Pathophysiology and preclinical relevance of experimental graft-versus-host disease in humanized mice
by: Grégory Ehx, et al.
Published: (2024-11-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULT PATIENTS WITH FANCONI ANEMIA.
by: hosein kamranzadeh fumani, et al.
Published: (2016-11-01)

More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses?
by: Moisés Manuel Gallardo-Pérez, et al.
Published: (2024-12-01)

Implementing a standardized workflow for early detection of steroid-induced hyperglycemia in allogeneic stem cell transplant recipients: A quality improvement project
by: Jordan Leal, et al.
Published: (2024-12-01)

Oral acute graft‐versus‐host disease
by: Farzad Teymouri, et al.
Published: (2024-12-01)

Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD
by: Jongbok Lee, et al.
Published: (2025-01-01)

Interspecies transcriptome profiles of human T cell activation and liver inflammation in a xenogeneic graft-versus-host disease model
by: Seo Yule Jeong, et al.
Published: (2024-12-01)

Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease
by: Taylor McManus, BS, MS, et al.
Published: (2025-01-01)

Gut microbiota and graft-versus-host disease in hematopoietic stem cell transplant patients
by: Pegah Panahi, et al.
Published: (2024-10-01)

Sustained descemetocele management with Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) treatment
by: Alexander M. Tseng, et al.
Published: (2024-12-01)

Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia
by: Sitânia Chiesa, et al.
Published: (2024-12-01)

Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
by: Susmitha Apuri, et al.
Published: (2014-02-01)

Application of lacrimal gland ultrasonography in the evaluation of chronic ocular graft-versus-host-disease
by: Mingxia Zhong, et al.
Published: (2025-02-01)

Unwanted disorders and xenogeneic graft‐versus‐host disease in experimental immunodeficient mice: How to evaluate and how to report
by: Seyed Mostafa Monzavi, et al.
Published: (2025-01-01)

Non-Invasive Diagnosis of Pediatric Intestinal Graft-Versus-Host Disease: A Case Series
by: Manuela Spadea, et al.
Published: (2022-03-01)

ST2 and Reg3α: Can they predict aGvHD, steroid refractoriness and transplant-related mortality in pediatric patients after HSCT?
by: Gökcan Öztürk, et al.
Published: (2024-12-01)

Posttransplantation course after allogeneic stem cell transplantation in a patient with advanced mycosis fungoides—Balancing relapse and rejection
by: Inga Hansen‐Abeck, et al.
Published: (2024-12-01)

The rationale behind grafting haploidentical hematopoietic stem cells
by: Richard T. Maziarz, et al.
Published: (2024-12-01)

Oral GVHD post-cardiac xenograft valve replacement: a case report
by: Sarah M. Nizar Feteih, et al.
Published: (2024-12-01)